The role of foam cells in spinal cord injury: challenges and opportunities for intervention

Front Immunol. 2024 Mar 13:15:1368203. doi: 10.3389/fimmu.2024.1368203. eCollection 2024.

Abstract

Spinal cord injury (SCI) results in a large amount of tissue cell debris in the lesion site, which interacts with various cytokines, including inflammatory factors, and the intrinsic glial environment of the central nervous system (CNS) to form an inhibitory microenvironment that impedes nerve regeneration. The efficient clearance of tissue debris is crucial for the resolution of the inhibitory microenvironment after SCI. Macrophages are the main cells responsible for tissue debris removal after SCI. However, the high lipid content in tissue debris and the dysregulation of lipid metabolism within macrophages lead to their transformation into foamy macrophages during the phagocytic process. This phenotypic shift is associated with a further pro-inflammatory polarization that may aggravate neurological deterioration and hamper nerve repair. In this review, we summarize the phenotype and metabolism of macrophages under inflammatory conditions, as well as the mechanisms and consequences of foam cell formation after SCI. Moreover, we discuss two strategies for foam cell modulation and several potential therapeutic targets that may enhance the treatment of SCI.

Keywords: cholesterol reverse transcription; foam cell; macrophage; scavenger receptor; spinal cord injury.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System / metabolism
  • Foam Cells* / pathology
  • Humans
  • Macrophages / metabolism
  • Spinal Cord Injuries* / metabolism

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the Fundamental Research Funds for Central Public Welfare Research Institutes (2023CZ-2) and the Fundamental Research Funds for Central Public Welfare Research Institutes (2019CZ-13).